Lucira Connect – All You Need For Covid Care From Home The Lucira Covid-19 Test provides 98% accurate, lab-quality results in 30 minutes or less. Now with Lucira Connect, you also get FREE telehealth ...

Lucira Health, Inc. LHDX shares are surging higher on Tuesday after the company announced it submitted an Emergency Use Authorization application to the FDA for over-the-counter use of its COVID-19 & ...

Lucira was the first at-home COVID-19 test authorized in Canada and has been used in public health programs and for safe travel Lucira is a medical technology company focused on the development and ...

New partnership enables a free Sesame telehealth consultation with purchase of a Lucira at-home COVID-19 test, providing a full test-to-treat experience from the comfort of home, within two hours NEW ...

EMERYVILLE, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, a developer of instrument-free, molecular infectious disease testing products, closed today on its $15 million Series B equity financing. The round ...

Lucira's tests are the only available at-home self-test kits that deliver PCR-quality accuracy and early detectability in a single-use test kit with results in 30 minutes Current surge of COVID-19 ...

Good afternoon, ladies and gentlemen, and welcome to the Lucira Health Third Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode. As a reminder, this ...

After rising sharply on Monday, shares of medical technology company Lucira Health (NASDAQ: LHDX) are going in the opposite direction on Tuesday. The company's stock dropped by as much as 22.6% today ...

Shares of Lucira Health (LHDX) exploded out of the gate when the company made its stock market debut in February. Despite an initial run-up, though, this new medical-technology stock has lost nearly ...

This analyst thinks the company's stock performance will trail that of the market. Bank of America analyst Derik de Bruin downgraded Lucira Health's stock to underperform from buy. The analyst also ...